Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users
Clinical trial NCT03059563 · TERMINATED
Trial details
- NCT number
- NCT03059563
- Sponsor
- University of California, Los Angeles
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-11
- Primary completion
- 2023-09-28
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.